These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16144880)

  • 21. Treatment of severe infections caused by Staphylococcus aureus: a change in the vancomycin paradigm?
    Aranha Camargo LF
    Shock; 2008 Oct; 30 Suppl 1():67-9. PubMed ID: 18704006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perinephric abscess caused by community-acquired methicillin resistant Staphylococcus aureus.
    Malik ZA; Litman N
    Pediatr Infect Dis J; 2007 Aug; 26(8):764. PubMed ID: 17848900
    [No Abstract]   [Full Text] [Related]  

  • 23. Therapy-resistant skin and soft tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus in a young immunocompetent adult.
    Graue N; Korber A; Schmid EN; Rath PM; Dissemond J
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):766-7. PubMed ID: 18482040
    [No Abstract]   [Full Text] [Related]  

  • 24. Healthy children with invasive community-acquired methicillin-resistant Staphylococcus aureus infections.
    Stankovic C; Mahajan PV
    Pediatr Emerg Care; 2006 May; 22(5):361-3. PubMed ID: 16714967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
    Hota B
    Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
    John CC; Schreiber JR
    Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
    Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
    J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Community-acquired methicillin-resistant Staphylococcus aureus disseminated disease].
    Brezzo C; Cecchini D; Biscione F; Orduna T; Costa N; Quinteros M
    Medicina (B Aires); 2006; 66(5):443-6. PubMed ID: 17137175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.
    Corne P; Marchandin H; Macia JC; Jonquet O
    Scand J Infect Dis; 2005; 37(11-12):946-9. PubMed ID: 16308242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
    Barberán J; Aguilar L; Carroquino G; Giménez MJ; Sánchez B; Martínez D; Prieto J
    Am J Med; 2006 Nov; 119(11):993.e7-10. PubMed ID: 17071171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G; Kamath S; Hussain A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection.
    Moise PA; Castro RS; Sul C; Forrest A; Sakoulas G
    Ann Pharmacother; 2008 Apr; 42(4):592-3. PubMed ID: 18349303
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of nasal mupirocin for eradicating meticillin-resistant Staphylococcus aureus: a dilemma?
    Afghani B; Kong V; Wu FL
    J Hosp Infect; 2006 Nov; 64(3):299-300. PubMed ID: 16979263
    [No Abstract]   [Full Text] [Related]  

  • 34. Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
    Hmouda H; Ben Salem C; Bouraoui K; Jemni L
    J Antimicrob Chemother; 2006 Dec; 58(6):1307; author reply 1307-8. PubMed ID: 17056611
    [No Abstract]   [Full Text] [Related]  

  • 35. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
    Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
    Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
    [No Abstract]   [Full Text] [Related]  

  • 36. [Folliculitis by methicillin-resistant Staphylococcus aureus in health workers].
    García Fernández D; Pedragosa Jové R; Castells Rodellas A
    Med Clin (Barc); 1999 Oct; 113(12):478-9. PubMed ID: 10570523
    [No Abstract]   [Full Text] [Related]  

  • 37. Eradication or decolonization of methicillin-resistant Staphylococcus aureus carriage: what are we doing and why are we doing it?
    Bradley SF
    Clin Infect Dis; 2007 Jan; 44(2):186-9. PubMed ID: 17173214
    [No Abstract]   [Full Text] [Related]  

  • 38. Comment on: linezolid use in sepsis due to methicillin-susceptible Staphylococcus aureus.
    De Beeck VO; Dhif N; Philipp J; De Bels D
    J Antimicrob Chemother; 2006 Mar; 57(3):577. PubMed ID: 16431858
    [No Abstract]   [Full Text] [Related]  

  • 39. Community-associated methicillin-resistant Staphylococcus aureus.
    Wallin TR; Hern HG; Frazee BW
    Emerg Med Clin North Am; 2008 May; 26(2):431-55, ix. PubMed ID: 18406982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.